SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-20-032705
Filing Date
2020-10-22
Accepted
2020-10-22 08:45:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea128740-425b5_enlivextherap.htm 424B5 329901
2 GRAPHIC image_001.jpg GRAPHIC 7311
  Complete submission text file 0001213900-20-032705.txt   341315
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232009 | Film No.: 201251787
SIC: 2834 Pharmaceutical Preparations